Press Release: European Medicines Agency recommends approval of new HIV medicine

Author (Corporate)
Series Title
Series Details EMA/715767/2013 (22.11.13)
Publication Date 22/11/2013
Content Type

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), in November 2013, recommended granting a marketing authorisation for Tivicay in combination with other antiretroviral medicines for the treatment of adults and adolescents over 12 years of age infected with human immunodeficiency virus (HIV).

Source Link Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/11/news_detail_001973.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Press Release: EMA/715767/2013 (22.11.13): European Medicines Agency recommends approval of new HIV medicine http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/11/WC500155478.pdf

Subject Categories
Countries / Regions